Venus Remedies Limited

NSEI:VENUSREM Stock Report

Market Cap: ₹4.2b

Venus Remedies Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Ashutosh Jain

Chief executive officer

₹7.1m

Total compensation

CEO salary percentage97.0%
CEO tenure17.5yrs
CEO ownershipn/a
Management average tenure3.8yrs
Board average tenure3.5yrs

Recent management updates

Shareholders May Not Be So Generous With Venus Remedies Limited's (NSE:VENUSREM) CEO Compensation And Here's Why

Sep 17
Shareholders May Not Be So Generous With Venus Remedies Limited's (NSE:VENUSREM) CEO Compensation And Here's Why

Recent updates

Shareholders May Not Be So Generous With Venus Remedies Limited's (NSE:VENUSREM) CEO Compensation And Here's Why

Sep 17
Shareholders May Not Be So Generous With Venus Remedies Limited's (NSE:VENUSREM) CEO Compensation And Here's Why

Venus Remedies Limited (NSE:VENUSREM) Held Back By Insufficient Growth Even After Shares Climb 26%

Jun 14
Venus Remedies Limited (NSE:VENUSREM) Held Back By Insufficient Growth Even After Shares Climb 26%

Venus Remedies (NSE:VENUSREM) Could Easily Take On More Debt

Jun 13
Venus Remedies (NSE:VENUSREM) Could Easily Take On More Debt

Venus Remedies Limited (NSE:VENUSREM) Not Doing Enough For Some Investors As Its Shares Slump 26%

Mar 14
Venus Remedies Limited (NSE:VENUSREM) Not Doing Enough For Some Investors As Its Shares Slump 26%

Calculating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)

Oct 31
Calculating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)

Venus Remedies (NSE:VENUSREM) Seems To Use Debt Rather Sparingly

Jun 03
Venus Remedies (NSE:VENUSREM) Seems To Use Debt Rather Sparingly

Estimating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)

Jul 15
Estimating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)

Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?

May 31
Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?

I Ran A Stock Scan For Earnings Growth And Venus Remedies (NSE:VENUSREM) Passed With Ease

Mar 30
I Ran A Stock Scan For Earnings Growth And Venus Remedies (NSE:VENUSREM) Passed With Ease

Why Investors Shouldn't Be Surprised By Venus Remedies Limited's (NSE:VENUSREM) 25% Share Price Plunge

Feb 24
Why Investors Shouldn't Be Surprised By Venus Remedies Limited's (NSE:VENUSREM) 25% Share Price Plunge

Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?

Feb 01
Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?

Here's Why We Think Venus Remedies (NSE:VENUSREM) Is Well Worth Watching

Nov 16
Here's Why We Think Venus Remedies (NSE:VENUSREM) Is Well Worth Watching

Venus Remedies Limited's (NSE:VENUSREM) Stock Is Going Strong: Have Financials A Role To Play?

Mar 11
Venus Remedies Limited's (NSE:VENUSREM) Stock Is Going Strong: Have Financials A Role To Play?

We Think Venus Remedies (NSE:VENUSREM) Is Taking Some Risk With Its Debt

Jan 14
We Think Venus Remedies (NSE:VENUSREM) Is Taking Some Risk With Its Debt

Does Venus Remedies's (NSE:VENUSREM) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 23
Does Venus Remedies's (NSE:VENUSREM) Statutory Profit Adequately Reflect Its Underlying Profit?

Is Venus Remedies (NSE:VENUSREM) A Risky Investment?

Sep 22
Is Venus Remedies (NSE:VENUSREM) A Risky Investment?

CEO Compensation Analysis

How has Ashutosh Jain's remuneration changed compared to Venus Remedies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹221m

Jun 30 2024n/an/a

₹285m

Mar 31 2024₹7m₹7m

₹285m

Dec 31 2023n/an/a

₹290m

Sep 30 2023n/an/a

₹255m

Jun 30 2023n/an/a

₹209m

Mar 31 2023₹7m₹7m

₹266m

Dec 31 2022n/an/a

₹157m

Sep 30 2022n/an/a

₹181m

Jun 30 2022n/an/a

₹359m

Mar 31 2022₹7m₹7m

₹407m

Dec 31 2021n/an/a

₹756m

Sep 30 2021n/an/a

₹816m

Jun 30 2021n/an/a

₹715m

Mar 31 2021₹4m₹4m

₹618m

Dec 31 2020n/an/a

₹213m

Sep 30 2020n/an/a

₹87m

Jun 30 2020n/an/a

-₹40m

Mar 31 2020₹3m₹3m

-₹100m

Dec 31 2019n/an/a

-₹161m

Sep 30 2019n/an/a

-₹269m

Jun 30 2019n/an/a

-₹269m

Mar 31 2019₹3m₹3m

-₹286m

Mar 31 2018₹3m₹3m

-₹307m

Compensation vs Market: Ashutosh's total compensation ($USD84.94K) is above average for companies of similar size in the Indian market ($USD42.81K).

Compensation vs Earnings: Ashutosh's compensation has been consistent with company performance over the past year.


CEO

Ashutosh Jain (47 yo)

17.5yrs

Tenure

₹7,145,217

Compensation

Mr. Ashutosh Jain, B.A., LL B serves as Chief Executive Officer at Venus Remedies Limited. He has been an Whole-Time Director of Venus Remedies Limited since May 2007 and serves as its Head of Legal, Regul...


Leadership Team

NamePositionTenureCompensationOwnership
Pawan Chaudhary
Chairman15.1yrs₹12.77m12.82%
₹ 532.6m
Ashutosh Jain
CEO, Head of Legalno data₹7.15mno data
Manu Chaudhary
Joint MDno data₹12.53m11.73%
₹ 487.3m
Akshansh Chaudhary
CTO & Executive Time Director3.8yrs₹5.19m0.000010%
₹ 415.4
Peeyush Jain
Deputy MDno data₹7.69m0.00037%
₹ 15.4k
Ajeet Kapoor
AVP of Accounts & Head CAAR Divisionno datano datano data
Jitendra Singh
Chief General Manager of Administrationno datano datano data
Neha Kodan
Company Secretary & Compliance Officer13.6yrsno datano data
Manav Soni
Senior Vice President of Plant & Commercial4.8yrsno datano data
Rakesh Pandita
Chief General Manager of Secretarial & Banking3.8yrsno datano data
Saransh Chaudhary
CEO of VMRC3.8yrsno datano data
Aditi Chaudhary
President International Business1.8yrsno datano data

3.8yrs

Average Tenure

53yo

Average Age

Experienced Management: VENUSREM's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Pawan Chaudhary
Chairman15.1yrs₹12.77m12.82%
₹ 532.6m
Ashutosh Jain
CEO, Head of Legal17.5yrs₹7.15mno data
Manu Chaudhary
Joint MD19.1yrs₹12.53m11.73%
₹ 487.3m
Akshansh Chaudhary
CTO & Executive Time Director2.5yrs₹5.19m0.000010%
₹ 415.4
Peeyush Jain
Deputy MDno data₹7.69m0.00037%
₹ 15.4k
Jagdish Sharma
Non-Executive Independent Directorless than a yearno datano data
Navdeep Sud
Independent Non-Executive Director4.4yrs₹80.00kno data
Savita Gupta
Independent Non-Executive Directorno data₹50.00kno data
NPS Monga
Independent Non-Executive Director1.5yrsno datano data
Anil Kumar
Non-Executive Independent Directorless than a yearno datano data

3.5yrs

Average Tenure

54yo

Average Age

Experienced Board: VENUSREM's board of directors are considered experienced (3.5 years average tenure).